This inventor holds 1 USPTO granted patent. Top assignee: Athena Diagnostics, Inc.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Kimberley Ottaway and Genetic Testing for X-Linked Charcot-Marie-Tooth Disease.
Introduction
Kimberley Ottaway is an inventor associated with Belmont, Massachusetts. Her patent work addresses genetic methods for detecting mutations linked to X-linked Charcot-Marie-Tooth (CMT) disease.
Latest Patents
Ottaway is associated with 1 patent, titled “Methods of Detecting Novel Mutations Relating to X-Linked” (the supplied title is incomplete). The patent describes methods for identifying connexin-32 gene mutations associated with X-linked CMT and diagnosing the disease. Approaches include hybridization analysis, restriction-digest testing, gene sequencing, allele-specific oligonucleotide hybridization, and identification of mutant connexin-32 proteins. It also describes mutant nucleic acid probes, proteins, and antibodies specific to those proteins.
Career Highlights
The supplied information associates Ottaway with Athena Diagnostics, Inc. Her patent reflects work on genetic testing methods that can help detect disease-associated mutations.
Collaborations
The supplied data names Uma Ananth and Michael Alan Boss as Ottaway’s coworkers. It does not specify their roles in the patent or describe particular collaborative contributions.
Conclusion
Kimberley Ottaway’s documented patent work focuses on detecting connexin-32 mutations and supporting the diagnosis of X-linked CMT disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
